G Peggy McFall
Overview
Explore the profile of G Peggy McFall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
430
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bohn L, Zheng Y, McFall G, Andrew M, Dixon R
J Alzheimers Dis
. 2025 Mar;
:13872877251319547.
PMID: 40025710
Background: Data-driven examination of multiple morbidities and deficits are informative for clinical and research applications in aging and dementia. Resulting profiles may change longitudinally according to dynamic alterations in extent,...
2.
Xu Y, McFall G, Ryden L, Skoog J, Chang E, Cysique L, et al.
Cereb Circ Cogn Behav
. 2025 Jan;
8():100375.
PMID: 39811568
Introduction: Cumulative blood pressure metrics may provide greater precision for measuring temporal risk exposure, especially in later life where data are mixed regarding associations of high blood pressure (BP) on...
3.
Bohn L, Han A, McFall G, Drouin S, Pettersen J, Rajah M, et al.
Innov Aging
. 2024 Nov;
8(11):igae094.
PMID: 39555391
Background And Objectives: Sex and gender are important topics of increasing interest in aging and dementia research. Few studies have jointly examined sex (as a biological attribute) and gender (as...
4.
Calvo N, McFall G, Ramana S, Galper M, Fuller-Thomson E, Dixon R, et al.
J Alzheimers Dis
. 2024 Nov;
102(1):119-128.
PMID: 39497303
Background: Bilateral oophorectomy (BO) confers immediate estradiol loss. We examined prevalence and predictors of Alzheimer's disease (AD) in women with early BO comparing their odds ratios of AD to those...
5.
Caballero H, McFall G, Gee M, MacDonald S, Phillips N, Fogarty J, et al.
J Alzheimers Dis
. 2024 Jun;
100(2):579-601.
PMID: 38875040
Background: Alzheimer's disease (AD) and Lewy body disease (LBD) are characterized by early and gradual worsening perturbations in speeded cognitive responses. Objective: Using simple and choice reaction time tasks, we...
6.
Bohn L, Drouin S, McFall G, Rolfson D, Andrew M, Dixon R
BMC Geriatr
. 2023 Dec;
23(1):837.
PMID: 38082372
Background: Frailty indicators can operate in dynamic amalgamations of disease conditions, clinical symptoms, biomarkers, medical signals, cognitive characteristics, and even health beliefs and practices. This study is the first to...
7.
McFall G, Bohn L, Gee M, Drouin S, Fah H, Han W, et al.
Front Aging Neurosci
. 2023 Jul;
15:1124232.
PMID: 37455938
Background: Persons with Parkinson's disease (PD) differentially progress to cognitive impairment and dementia. With a 3-year longitudinal sample of initially non-demented PD patients measured on multiple dementia risk factors, we...
8.
Bohn L, McFall G, Gee M, Postuma R, Dixon R, Camicioli R
Can Geriatr J
. 2023 Mar;
26(1):176-186.
PMID: 36865405
Background: Parkinson's disease (PD) increases risk for dementia and cascading adverse outcomes. The eight-item Montreal Parkinson Risk of Dementia Scale (MoPaRDS) is a rapid, in-office dementia screening tool. We examine...
9.
Heal M, McFall G, Vergote D, Jhamandas J, Westaway D, Dixon R
J Alzheimers Dis
. 2022 Jul;
89(1):265-281.
PMID: 35871342
Background: A promising risk loci for sporadic Alzheimer's disease (AD), Bridging Integrator 1 (BIN1), is thought to operate through the tau pathology pathway. Objective: We examine BIN1 risk for a...
10.
Drouin S, McFall G, Potvin O, Bellec P, Masellis M, Duchesne S, et al.
J Alzheimers Dis
. 2022 May;
88(1):97-115.
PMID: 35570482
Background: Hippocampal atrophy is a well-known biomarker of neurodegeneration, such as that observed in Alzheimer's disease (AD). Although distributions of hippocampal volume trajectories for asymptomatic individuals often reveal substantial heterogeneity,...